Filing Details
- Accession Number:
- 0001209191-20-047575
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-08-19 17:43:08
- Reporting Period:
- 2020-08-17
- Accepted Time:
- 2020-08-19 17:43:08
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1367920 | Concert Pharmaceuticals Inc. | CNCE | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1618060 | A. Marc Becker | C/O Concert Pharmaceuticals, Inc. 65 Hayden Avenue, Suite 3000N Lexington MA 02421 | Chief Financial Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2020-08-17 | 2,875 | $10.24 | 53,434 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Footnotes
- This sale was effected pursuant to a Rule 10b5-1 trading plan.
- These shares were sold to satisfy tax obligations associated with the vesting of restricted stock units.
Billionaire Hedge Funds
